Caribou Biosciences receives FDA RMAT designation for CB-011 therapy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. PRIM
2. ABBV
3. META
4. DPZ
5. IBM
6. CNC
7. KFY
8. SPY
9. MU
10. ENRD

Go back to Caribou Biosciences receives FDA RMAT designation for CB-011 therapy
(NASDAQ: CRBU) Delayed: 1.64 --0 (-0%)
Previous Close $1.64    52 Week High $ 
Open $1.64    52 Week Low $ 
Day High $1.64    P/E N/A 
Day Low $1.64    EPS $ 
Volume 6,461